BrightGene Bio Medical Technology C (688166) — Net Asset Momentum
BrightGene Bio Medical Technology C (688166) recorded a net asset momentum of 0.8% as of December 2024, with net assets of CN¥2.44 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See shareholders equity of BrightGene Bio Medical Technology C for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
BrightGene Bio Medical Technology C Net Asset Momentum (2016–2024)
This chart tracks BrightGene Bio Medical Technology C's year-over-year net asset growth across 9 annual reporting periods from 2016 to 2024. The most recent momentum reading is +0.8%, with net assets of CN¥2.44 Billion CNY as of December 2024. For live market cap and overall valuation, see market cap of BrightGene Bio Medical Technology C.
Annual Net Asset History for BrightGene Bio Medical Technology C (2016–2024)
The table below shows the complete annual net asset history for BrightGene Bio Medical Technology C from 2016 to 2024, covering 9 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check 688166 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥2.44 Billion | CN¥5.16 Billion | CN¥2.73 Billion | ▲ +0.8% |
| 2023 | CN¥2.42 Billion | CN¥5.03 Billion | CN¥2.61 Billion | ▲ +7.8% |
| 2022 | CN¥2.24 Billion | CN¥4.66 Billion | CN¥2.42 Billion | ▲ +28.7% |
| 2021 | CN¥1.74 Billion | CN¥2.97 Billion | CN¥1.23 Billion | ▲ +21.6% |
| 2020 | CN¥1.43 Billion | CN¥1.83 Billion | CN¥395.23 Million | ▲ +9.1% |
| 2019 | CN¥1.31 Billion | CN¥1.42 Billion | CN¥108.21 Million | ▲ +69.9% |
| 2018 | CN¥772.85 Million | CN¥878.37 Million | CN¥105.52 Million | ▲ +73.3% |
| 2017 | CN¥446.02 Million | CN¥524.92 Million | CN¥78.89 Million | ▲ +102.6% |
| 2016 | CN¥220.15 Million | CN¥384.19 Million | CN¥164.05 Million | — |